My Size, Inc. filed its quarterly report on Form 10-Q with the SEC on November 19, 2026, covering the nine-month and three-month periods ended September 30, 2026, and reporting a net loss of $5,025 thousand for the nine months ended on that date.

Key Highlights

  • Net loss of $5,025 thousand for the nine months ended September 30, 2026, compared to a net loss of $2,845 thousand for the same period in 2025, according to the filing.
  • Revenue of $7,322 thousand for the nine months ended September 30, 2026, up from $6,057 thousand in the comparable prior-year period.
  • Total assets declined to $7,104 thousand as of September 30, 2026, from $10,204 thousand as of December 31, 2025.
  • Accumulated deficit reached $74,753 thousand as of September 30, 2026, compared to $69,728 thousand at December 31, 2025.
  • Shares outstanding were 1,312,256 as of November 19, 2026, as disclosed on the cover page of the filing.
  • PIPE and ATM equity issuances raised net proceeds of approximately $2,117 thousand and $682 thousand, respectively, during the nine-month period, according to the filing.

My Size Financial Results and Balance Sheet Position for Q3 2026

According to the Form 10-Q filed November 19, 2026, My Size, Inc. (NASDAQ:MYSZ) reported revenues of $7,322 thousand for the nine months ended September 30, 2026, an increase from $6,057 thousand in the nine months ended September 30, 2025. For the three months ended September 30, 2026, the company reported revenues of $1,858 thousand, compared to $2,572 thousand in the same quarter of 2025. Gross profit for the nine-month period was $2,504 thousand, down from $2,553 thousand a year earlier.

The company disclosed total operating expenses of $7,307 thousand for the nine months ended September 30, 2026, resulting in an operating loss of $4,803 thousand. This compares to an operating loss of $3,002 thousand in the same period of 2025. General and administrative expenses increased to $3,724 thousand from $2,735 thousand, and research and development expenses rose to $852 thousand from $355 thousand, according to the filing. Basic and diluted loss per share for the nine-month period was $(7.01), based on a weighted average share count of 716,516, after giving effect to a reverse stock split noted in the filing.

The condensed consolidated interim balance sheet as of September 30, 2026, reflected total stockholders' equity of $3,374 thousand, down from $5,157 thousand at December 31, 2025. Total liabilities decreased to $3,730 thousand from $5,047 thousand. The company issued shares and pre-funded warrants in a private placement (PIPE), net of $383 thousand in issuance costs, contributing $2,117 thousand to additional paid-in capital, and issued shares under an At The Market Offering Agreement net of $26 thousand in costs, adding $682 thousand. Common stock shares issued and outstanding as of September 30, 2026, were 878,355, reflecting multiple issuances during the period as detailed in the statements of changes in stockholders' equity.

What Was Disclosed

My Size, Inc. disclosed its unaudited condensed consolidated interim financial statements for the nine and three months ended September 30, 2026, including statements of comprehensive loss, balance sheets, and changes in stockholders' equity, in a Form 10-Q filed November 19, 2026.